This raises the possibility of AP-1 acting as a mediator of inappropriate chromatin remodeling and cellular activation/senescence in multiple cell types, with evidence from our analysis of persisting differential chromatin accessibility, gene expression signatures, and cell protein markers of activation that may contribute to both acute disease and post-COVID-19 syndrome. The gene discussed is JUN; the disease is glycogen storage disease VI.